Medtronic has appointed John Groetelaars and Bill Jellison to its board as independent directors, effective immediately, and formed two board committees.

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

Jellison currently serves as a Senior Advisor for Astor Place Holdings, the Private Equity arm of Select Equities, and ...

Q1 2026 Earnings Call Transcript August 19, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.26, ...

Medtronic: The company did not raise the sales growth forecast for its fiscal 2026 despite strong quarterly results, sending ...

Medtronic PLC (MDT) reports robust growth across key segments, raises full-year EPS guidance, and outlines strategic ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Medtronic(NYSE:MDT) reported first quarter fiscal 2026 results on August 19, 2025, delivering 4.8% year-over-year organic revenue growth and adjusted earnings per share (EPS) of $1.26, which beat the ...

Medtronic officials today said that the company's planned separation of its Diabetes business is on the right track.

Medtronic appoints two new board directors following talks with activist investor Elliott Investment Management.

"Are we investing enough behind these big growth drivers? We think no. We want to invest more," Medtronic CEO Geoff Martha ...

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott ...